NCT00641836View on ClinicalTrials.gov

Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

December 31, 2007

Conditions

Idiopathic Pulmonary Arterial Hypertension

Interventions

PROCEDURE

Transplantation of autologous endothelial progenitor cells

Trial Locations (1)

310003

Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors

lead

Zhejiang University

OTHER

NCT00641836 - Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter